株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

インスリンデリバリーシステム

Insulin Delivery Systems

発行 Global Industry Analysts, Inc. 商品コード 121149
出版日 ページ情報 英文 435 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
インスリンデリバリーシステム Insulin Delivery Systems
出版日: 2010年04月01日 ページ情報: 英文 435 Pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当レポートでは、世界のインスリンデリバリーシステム市場について分析し、糖尿病の概要とリスクファクター、治療法とともに、インスリンデリバリーシステムの概要、製品開発動向をまとめ、市場に参入する企業のプロファイルと各国市場別の動向を交え、概略以下の構成でお届けします。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • 増加する糖尿病の罹患率:主な成長促進因子
    • 糖尿病:途上国で増加
    • 糖尿病管理のためのインスリン療法
    • インスリンデリバリーシステム:概要
    • インスリンデリバリーにおける技術革新
    • 次世代インスリンデリバリー技術および装置
  • 主な動向と課題
    • プレフィルシリンジ
    • インスリンポンプ市場
    • 革新的性能
    • 併用製品
    • 埋め込みインスリンポンプ
    • 保証期間の満了
    • インスリンポンプ市場の課題
  • 糖尿病とインスリンデリバリーシステム
    • 糖尿病:致命的疾患
    • 糖尿病のリスクファクター
    • 糖尿病の種類
    • 糖尿病の長期的合併症
    • 膵臓:人体でのインスリン源
    • インスリンの種類と投与
    • インスリン療法の目的
    • インスリンデリバリーシステム
  • 研究開発
  • 製品導入
  • 近年の業界活動
  • 主要参入企業
    • Animas Corporation
    • Antares Pharma, Inc.
    • Becton, Dickinson and Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche, Ltd.
    • Generex Biotechnology Corp.
    • Insulet Corp.
    • Medical Plastic Devices Inc.
    • Medtronic Inc.
    • Novo Nordisk A/S
    • Patton Medical Devices, LP
    • Sanofi-Aventis
    • Smiths Medical MD, Inc.
    • Ypsomed AG
  • 世界市場見通し

第3章 市場

  • 米国
  • 欧州
  • その他の諸国

第3章 競合環境

  • 企業プロファイル:72社(部署/子会社含め82社)
    • 米国
    • カナダ
    • 日本
    • 欧州
    • アジア太平洋諸国(日本を除く)
    • 中東
目次
Product Code: MCP-6283

Abstract

This report analyzes the worldwide markets for Insulin Delivery Systems in US$ Million by the following major Insulin Delivery Mechanisms - Insulin Syringes, Insulin Pumps (External), and Insulin Pens. The report provides separate comprehensive analytics for US, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2007 through 2015. Also, a six-year historic analysis is provided for these markets. The report profiles 72 companies including many key and niche players worldwide such as Animas Corporation, Antares Pharma, Inc., Becton, Dickinson and Company, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Disetronic Medical Systems, Inc., Generex Biotechnology Corp., Insulet Corp, Medical Plastic Devices Inc., Medtronic Inc., Novo Nordisk A/S, Patton Medical Devices, LP, Sanofi-Aventis, Smiths Medical MD, Inc., and Ypsomed AG. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
  • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Increasing Diabetes Prevalence - A Major Growth Propeller
  • Diabetes - Taking Toll in Developing Countries
  • Insulin Therapy for Diabetes Management
  • Insulin Delivery Systems - A Quick Market Primer
  • Insulin Pump Therapy: Convenient Alternate to Insulin Injection
  • United States - The Largest Global Market for Insulin Pumps (External)
  • Rosy Future Ahead for Insulin Pens
  • Select Brands of Disposable Insulin Pens by Manufacturer
  • Select Brands of Reusable Insulin Pens by Manufacturer
  • Innovations in Insulin Delivery - An Overview
  • Select Next-Generation Insulin Delivery Techniques and Devices
  • Pulmonary Insulin Delivery via Inhalers
  • Early Jitters Make Pharma Majors Abandon Inhaled Insulin Research
  • Pulmonary Insulin Delivery Research Still Remains Unabated
  • Transdermal Delivery of Insulin via Patches
  • Transmucosal Insulin Delivery via Mouth Spray
  • Nasal Delivery of Insulin via Nasal Mucosa
  • Hydrogels for Insulin Delivery
  • Oral Insulin Delivery
  • Artificial Pancreas Technology - A Promising Approach for Diabetes Treatment
  • Competitive Landscape
  • Insulin Syringes
  • Insulin Pumps
  • Insulin Pens

2. MAJOR TRENDS & ISSUES

  • Pre-Filled Syringes: Gaining Diabetics Attention
  • Insulin Pumps Market: Tough Ground for New Entrants
  • Innovative Features Spruce Up the Market for Insulin Pumps
  • Combination Products: The Latest Trend in the Insulin Pump Market
  • Implantable Insulin Pumps: Emerging Technology in the Insulin Pump Market
  • Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
  • Insulin Pump Market Issues
  • Insulin Pump Training Not Receiving Adequate Attention
  • Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged

3. DIABETES & INSULIN DELIVERY SYSTEMS - AN ABSTRACT

  • Diabetes - A Fatal Disease
  • Risk Factors for Diabetes
  • Types of Diabetes
  • Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM)
  • Type II Diabetes: Non Insulin-Dependent Diabetes Mellitus (NIDDM)
  • Long Term Complications of Diabetes
  • Pancreas: The Main Source of Insulin in Human Body
  • Types of Insulin & Administration
  • Oral Administration
  • Goal of Insulin Therapy
  • Insulin Delivery Systems - An Overview
  • Insulin Syringes
  • Insulin Needles
  • Insulin Pens
  • Advantages of Insulin Pens
  • Disadvantages of Insulin Pens
  • External Insulin Pumps
  • Insulin Pump Components
  • How Does an Insulin Pump Work?
  • Insulin Pump Delivery Rates
  • Advantages of Insulin Pumps
  • More Accurate and Consistent
  • Adjusting Time Zones While Traveling
  • Enhances Blood Sugar Control in Pediatric Patients
  • Improves Quality of Life
  • Disadvantages of Insulin Pumps
  • High Cost
  • High Involvement
  • Diabetic Ketoacidosis Risk
  • Glucose Testing at Regular Intervals
  • Regular Rotation of Infusion Set
  • Carrying Back-up Kit
  • Regular Refilling of Pump
  • Insulin Jet Injectors
  • Pen Injectors

4. RESEARCH & DEVELOPMENT

  • Nanotechnology Victoria, Monash University Develop SAW Generated Mechanism, for Insulin Delivery
  • Medtronic Emphasizes Cutting-Edge Features of a Closed-Loop Diabetes Management System, Currently Under Development
  • Toray Industries and Hoshi University Discover a New Approach for Insulin Delivery Via Nasal Spray
  • A New Study Demonstrates Superior Benefits of Novo Nordisk' s Next Generation
  • Phosphagenics to Commence Phase II Clinical Trials of Transdermal Insulin Delivery System
  • Oramed Pharmaceuticals Begins Phase Ia Trials of Insulin Suppository
  • Debiotech and STMicroelectronics Unveil First Prototype of a Disposable Insulin Nanopump
  • Braunschweig University Scholar Devises Wristwatch Insulin Pump

5. PRODUCT INTRODUCTIONS

  • Novo Nordisk Introduces Preloaded Pen
  • BD Medical Unveils BD AutoShield Pen Needle
  • Novo Nordisk Introduces Flexpen
  • Polymedicure Unveils Insulin syringes
  • Johnson & Johnson Medical India to Unveil Insulin Pumps
  • Generex Rolls Out Oral Insulin Spray
  • Eli Lilly Launches KwikPen
  • Smith Medical Launches Cozmo in China
  • Medtronic Unveils Arabic Language Insulin Pump
  • Medtronic Launches New Diabetes Monitoring System
  • Eli Lilly to Unveil New Insulin Pen, Memoir

6. RECENT INDUSTRY ACTIVITY

  • JDRF Enters into Partnership with Animas
  • Medtronic Acquires Certain Assets from PreciSense
  • MannKind Inks Agreement to Acquire Pfizer' s German Insulin Facility
  • Owen Mumford Inks Deal with Sanofi-Aventis
  • Medingo Obtains FDA Approval for Marketing Insulin Micropump
  • Insulet Wins CE Mark Approval for OmniPod® Insulin Management System
  • Sanofi-aventis Receives FDA Approval for Apidra® SoloSTAR®
  • Novo Nordisk Receives FDA Approval for NovoLog® Labeling Change
  • Patton Medical Devices, Unomedical Enter into Partnership Agreement
  • Sanofi-aventis Wins Canadian and EU Approval for ClikSTAR® Insulin Pen
  • DexCom and Animas Amend Insulin Pump Joint Development Deal
  • Medingo Secures FDA Approval for Solo MicroPump Insulin Delivery System
  • Qualitest Pharmaceuticals Recalls Accusure Insulin Syringes
  • Novartis Completes Acquisition of Nektar' s Pulmonary Business
  • Smiths Medical Acquires Zhejiang Zheda Medical Instrument
  • ICBS Acquires Vectoris Pharma
  • Sagent Pharma Acquires Rights to ChaSyr, a Multi-Chamber Syringe
  • Novo Nordisk Hands Over Inhaled Insulin Patents to Aradigm
  • Eli Lilly and Alkermes Terminate Inhaled Insulin Development Deal
  • Novo-Nordisk Drops Development Plan of Inhaled Insulin
  • Generex, Dongsung Pharm Enter Agreement for Generex Oral-lyn
  • Novo Nordisk Gains FDA Clearance for NovoLog®
  • Novo Nordisk to Construct Insulin Plant in China
  • Generex Biotechnology Enters into Distribution Agreement with SciGen
  • Rexam and Eli Lilly to Expand Manufacturing Base for Insulin Pens
  • Merrion to Develop and Market Novo Nordisk' s Insulin Analogues
  • Smiths Medical to Cease Insulin Pumps Sale, Exist Diabetes Business
  • Covidien Recalls Mislabelled Syringes
  • Animas Recalls Insulin Pumps with Faulty Battery Cap
  • NationsHealth Acquires Diabetes Care & Education
  • Insulet Inks Agreement with DexCom
  • Insulet Partners with Flextronics
  • Debiotech Allies with STMicroelectronics
  • SpectRx Divests Insulin Pump Business

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Animas Corporation (USA)
  • Antares Pharma, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • Eli Lilly and Company (USA)
  • F. Hoffmann-La Roche, Ltd. (Switzerland)
    • Disetronic Medical Systems, Inc. (USA)
    • Generex Biotechnology Corp. (Canada)
    • Insulet Corp. (USA)
    • Medical Plastic Devices Inc. (Canada)
    • Medtronic Inc. (USA)
    • Novo Nordisk A/S (Denmark)
    • Patton Medical Devices, LP (USA)
    • Sanofi-Aventis (France)
    • Smiths Medical MD, Inc. (USA)
    • Ypsomed AG (Switzerland)

8. GLOBAL MARKET PERSPECTIVE

  • Insulin Syringes:
  • Table 1: World Recent Past, Current & Future Analysis for Insulin Syringes Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
  • Table 2: World Historic Review for Insulin Syringes Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 3: World 15-year Perspective for Insulin Syringes Market by Geographic Region - Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)
  • Insulin Pumps (External):
  • Table 4: World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
  • Table 5: World Historic Review for Insulin Pumps (External) Market by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
  • Table 6: World 15-year Perspective for Insulin Pumps (External) Market by Geographic Region - Percentage Breakdown of Value Sales for US, Europe and Rest of World Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)
  • Insulin Pens:
  • Table 7: US and Europe Recent Past, Current & Future Analysis for Insulin Pens Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
  • Table 8: US and Europe Historic Review for Insulin Pens Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Diabetes - A Cause of Concern
    • Table 9: Diabetes Prevalence by Diabetes Type in Millions in the US (2008) (includes corresponding Graph/Chart)
    • Surging Diabetic Population Keeps Demand Ticking for Insulin Delivery Systems
    • External Insulin Pumps: A Key Mechanism for Insulin Delivery
    • Insulin Pens Gaining Immense Prominence
    • Jet Injectors: The Costliest Insulin Delivery System
    • Competitive Analysis by Insulin Delivery System
    • Becton Dickinson - The Insulin Syringes Market Leader
    • Table 10: US Insulin Syringes Market (2007): Percentage Share Breakdown by Leading Companies - Becton Dickinson, Kendall, and Others (includes corresponding Graph/Chart)
    • Medtronic - The Insulin Pumps Major
    • Table 11: US Insulin Pumps Market (2008): Percentage Share Breakdown of Leading insulin Pump Manufacturers - Medtronic, Animas and Others Comparison of Major Insulin Pump Systems Based on Select Parameters (includes corresponding Graph/Chart)
    • Product Introductions
    • Strategic Corporate Developments
    • Major Players
  • B. Market Analytics
    • Table 12: US Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 13: US Historic Review for Insulin Delivery Systems - Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 14: US 10-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)

2. EUROPE

  • A. Market Analysis
    • European Preference for Insulin Pens Overshadows the Rest of the World Demand
    • Insulin Pump Therapy Gaining Favor Among Europeans
    • Strategic Corporate Developments
    • Major Players
  • B. Market Analytics
    • Table 15: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 16: Europe Historic Review for Insulin Delivery Systems - Insulin Syringes, Insulin Pens and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 17: Europe 10-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes, Insulin Pens, and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015 (includes corresponding Graph/Chart)

3. REST OF WORLD

  • A. Market Analysis
    • Product Introductions
    • Strategic Corporate Developments
    • Major Players
  • B. Market Analytics
    • Table 18: Rest of World Recent Past, Current & Future Analysis for Insulin Delivery Systems - Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
    • Table 19: Rest of World Historic Review for Insulin Delivery Systems - Insulin Syringes and Insulin Pumps (External) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
    • Table 20: Rest of World 10-year Perspective for Insulin Delivery Systems - Percentage Breakdown of Value Sales for Insulin Syringes and Insulin Pumps (External) Markets for Years 2003, 2009 & 2015

IV. COMPETITIVE LANDSCAPE

Back to Top